Hannah Leah David, PA-C

Hannah David practices at Clemson Eye, PA in Greenville, South Carolina.

Hannah David's NPI, 1205615663, was assigned on September 25, 2023. Hannah David holds South Carolina license 4972.

Hannah David's primary practice is Clemson Eye, PA, at 360 Pelham Rd, Greenville, SC 29615 in Greenville County. The practice phone is (864) 654-6706.

Hannah David's primary practice is Clemson Eye, PA in Greenville, South Carolina. The medical group on file is iTrust Cares. Dmand AI also links Hannah David to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hannah David practices. Vendor and product names are available with a free account.

Geriatric psychiatry is Hannah David's primary specialty in the NPI Registry, under taxonomy code 2084P0805X. Hannah David is licensed in South Carolina.

CMS data shows 1,191 Medicare services from Hannah David across 4 procedure codes in 2024, for 113 Medicare patients. Medicare paid $84,242 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Hannah David in 2024. The largest group is 85 and over, with 55 patients. 75% of them have alzheimer's and dementia, and 75% have anxiety. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hannah David's median patient age at 83, with 56% women.

In 2024, Hannah David wrote 1,640 Medicare Part D claims for 129 patients. 95% of them were for generic drugs. CMS names the drug for 1,506 of them, across 26 drugs with 11 or more claims each, at $72,905 in total drug cost. In 2023, CMS named 87 claims across 5 drugs.

Hannah David accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Hannah David from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $138.